A methodological pipeline for the preclinical evaluation of novel topical agents for the treatment of CRS.
Int Forum Allergy Rhinol
; 2024 Jul 16.
Article
en En
| MEDLINE
| ID: mdl-39010849
ABSTRACT
KEY POINTS Novel topical therapeutics require extensive pre-clinical testing to assess efficacy and safety. Antibiofilm or immunosuppressant agents can utilize ex vivo models to measure ciliotoxicity. Agents that are found to be effective and non-toxic ex vivo warrant further investigation in vivo.
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Int Forum Allergy Rhinol
Año:
2024
Tipo del documento:
Article
País de afiliación:
Nueva Zelanda